Divastin-E 20/10 Tablet 20 mg + 10 mg Tablet

    Divastin-E 20/10 Tablet 20 mg + 10 mg

    Atorvastatin + Ezetimibe

    Category: Tablet

    Manufacturer: Drug International Ltd., Gopalpur

    Uses of Divastin-E 20/10 Tablet: - High cholesterol Hypercholesterolaemia, Primary Hyperlipidemia Hypersensitivity; active liver disease or unexplained persistent elevated liver function tests. Pregnancy and lactation.
    How to use Atorvastatin + Ezetimibe: Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Atorvastatin + Ezetimibe may be taken with or without food, but it is better to take it at a fixed time. Administration: May be taken with or without food. Adult Dose: Oral Hypercholesterolaemia Adult: Per tablet contains atorvastatin 10 mg and ezetimibe 10 mg: Usual starting: 1 tablet once daily. Child Dose: Safety and efficacy not established
    Atorvastatin: Increases digoxin levels; increases anticoagulant effect of warfarin. Avoid the combination of HMG-CoA reductase inhibitors and fibrates. Ezetimibe: Cholestyramine decreases AUC of ezetimibe by approx 55%; ciclosporin may increase ezetimibe levels. Potentially Fatal: Antacids decrease atorvastatin levels; colestipol decreases atorvastatin plasma levels; propranolol decreases antihyperlipidaemic activity of atorvastatin.
    Hypersensitivity; active liver disease or unexplained persistent elevated liver function tests. Pregnancy and lactation.
    Common - Nausea - Constipation - Stomach pain - Headache - Muscle pain - Increased liver enzymes - Increased glucose level in blood 1-10% Increased ALT (5%),Increased AST (4%),Musculoskeletal pain (4%),Abdominal pain (3%),Nausea (3%),Arthralgias (3%),Muscle weakness (2%),Dizziness (2%),Hyperkalemia (2%),Hot flushes (2%),Coughing (2%),Bronchitis (2%),Sinusitis (2%)
    Precaution: Hepatic impairment; patients consuming substantial quantities of alcohol with a history of liver disease. Not recommended for use in children <10 yr. Lactation: Because of the potential for adverse reactions in nursing infants, women taking this drug should not breast feed. Contraindicated in breastfeeding women.
    No specific treatment of overdosage can be recommended. In the event of an overdose, the patient should be treated symptomatically, and supportive measures instituted as required.
    Do not store above 30°C. Keep in a dry place. Protect from light and keep out of the reach of children.
    Other lipid regulating drugs
    Atorvastatin competitively inhibits HMG-CoA reductase, the enzyme that catalyses the conversion of HMG-CoA to mevalonate which is an early rate-limiting step in cholesterol biosynthesis. Ezetimibe inhibits the absorption of cholesterol from the intestine, thus decreasing the delivery of intestinal cholesterol to the liver.
    Pregnancy Category: X Lactation: Because of the potential for adverse reactions in nursing infants, women taking this drug should not breast feed. Contraindicated in breastfeeding women.
    Profile avater

    Samm Care